Medicines Company Receives European Approval for Angiox

The Medicines Company announced Tuesday that it has received European approval for the use of Angiox (bivalirudin) as an anticoagulant in patients with heart attacks … undergoing emergency heart procedures called primary percutaneous coronary intervention.
CNNMoney